Literature DB >> 1346925

Cloning of the essential myotonic dystrophy region and mapping of the putative defect.

C Aslanidis1, G Jansen, C Amemiya, G Shutler, M Mahadevan, C Tsilfidis, C Chen, J Alleman, N G Wormskamp, M Vooijs.   

Abstract

Myotonic dystrophy is a common dominant disorder (global incidence of 1:8,000) with variable onset and a protean nature of symptoms mainly involving progressive muscle wasting, myotonia and cataracts. To define the molecular defect, we have cloned the essential region of chromosome 19q13.3, including proximal and distal markers in a 700-kilobase contig formed by overlapping cosmids and yeast artificial chromosomes (YACs). The central part of the contig bridges an area of about 350 kilobases between two new flanking crossover borders. This segment has been extensively characterized through the isolation of five YAC clones and the subsequent subcloning in cosmids from which a detailed EcoRI, HindIII, MluI and NotI restriction map has been derived. Two genomic probes and two homologous complementary DNA probes were isolated using the cosmids. These probes are all situated within approximately 10 kilobases of genomic DNA and detect an unstable genomic segment in myotonic dystrophy patients. The length variation in this segment shows similarities to the instability seen at the fragile X locus. The physical map location and the genetic characteristics of the length polymorphism is compatible with a direct role in the pathogenesis of myotonic dystrophy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346925     DOI: 10.1038/355548a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  129 in total

Review 1.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Specific molecular prenatal diagnosis for the CTG mutation in myotonic dystrophy.

Authors:  J Myring; A L Meredith; H G Harley; G Kohn; G Norbury; P S Harper; D J Shaw
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

3.  Instability versus predictability: the molecular diagnosis of myotonic dystrophy.

Authors:  G K Suthers; S M Huson; K E Davies
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

4.  Segregation distortion of the CTG repeats at the myotonic dystrophy (DM) locus: new data from Brazilian DM families.

Authors:  M Zatz; A Cerqueira; M Vainzof; M R Passos-Bueno
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

Review 5.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 6.  The Role of RNA in Biological Phase Separations.

Authors:  Marta M Fay; Paul J Anderson
Journal:  J Mol Biol       Date:  2018-05-10       Impact factor: 5.469

7.  Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.

Authors:  Bradley A Hardin; Miriam R Lowe; Deepak Bhakta; William J Groh
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

8.  Comparison of CTG repeat length expansion and clinical progression of myotonic dystrophy over a five year period.

Authors:  L Martorell; J M Martinez; N Carey; K Johnson; M Baiget
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

9.  Direct molecular analysis of myotonic dystrophy in the German population: important considerations in genetic counselling.

Authors:  A Meiner; C Wolf; N Carey; A Okitsu; K Johnson; P Shelbourne; B Kunath; W Sauermann; H Thiele; P Kupferling
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

10.  The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects.

Authors:  W Reardon; R Newcombe; I Fenton; J Sibert; P S Harper
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.